SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE
|
0.710 |
GeneticVariation
|
disease |
BEFREE |
Novel splice-site variant of UCHL1 in an Indian family with autosomal recessive spastic paraplegia-79.
|
29735986 |
2018 |
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Novel UCHL1 mutations reveal new insights into ubiquitin processing.
|
28007905 |
2017 |
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration.
|
23359680 |
2013 |
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE
|
0.710 |
GermlineCausalMutation
|
disease |
ORPHANET |
Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration.
|
23359680 |
2013 |
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration.
|
23359680 |
2013 |
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Intron-exon structure of ubiquitin c-terminal hydrolase-L1.
|
10048490 |
1998 |
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE
|
0.710 |
Biomarker
|
disease |
CTD_human |
|
|
|
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE
|
0.710 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE
|
0.710 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
PARKINSON DISEASE 5, AUTOSOMAL DOMINANT
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants.
|
12705903 |
2003 |
PARKINSON DISEASE 5, AUTOSOMAL DOMINANT
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility.
|
12408865 |
2002 |
PARKINSON DISEASE 5, AUTOSOMAL DOMINANT
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Intron-exon structure of ubiquitin c-terminal hydrolase-L1.
|
10048490 |
1998 |
PARKINSON DISEASE 5, AUTOSOMAL DOMINANT
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
The ubiquitin pathway in Parkinson's disease.
|
9774100 |
1998 |
PARKINSON DISEASE 5, AUTOSOMAL DOMINANT
|
0.700 |
SusceptibilityMutation
|
disease |
CLINVAR |
|
|
|
PARKINSON DISEASE 5, AUTOSOMAL DOMINANT
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Non-Small Cell Lung Carcinoma
|
0.330 |
AlteredExpression
|
disease |
BEFREE |
Higher levels of UCHL1 mRNA in EVs were found in the samples of patients with early-stage HGNECs than those with early-stage NSCLC and healthy donors' EVs.
|
31845438 |
2020 |
Liver carcinoma
|
0.330 |
Biomarker
|
disease |
BEFREE |
Upregulation of Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Mediates the Reversal Effect of Verapamil on Chemo-Resistance to Adriamycin of Hepatocellular Carcinoma.
|
29627846 |
2018 |
Liver carcinoma
|
0.330 |
Biomarker
|
disease |
BEFREE |
The upregulation of NAE1, UBE2M, and UCHL1 in HCC was associated with aggressive characteristics and poor OS and RFS in patients with HCC after hepatectomy.
|
29846044 |
2018 |
Non-Small Cell Lung Carcinoma
|
0.330 |
AlteredExpression
|
disease |
BEFREE |
UCH-L1 expression in NSCLC cell lines H838 and H157 was modulated by siRNA-knockdown, and the phenotypic changes were assessed by flow cytometry, haematoxylin & eosin (H&E) staining and poly (ADP-ribose) polymerase (PARP) cleavage.
|
21878121 |
2011 |
Non-Small Cell Lung Carcinoma
|
0.330 |
Biomarker
|
disease |
BEFREE |
We identified 8 methylated genes (ARPC1B, DNAH9, FLRT2, G0S2, IRS2, PKP1, SPOCK1 and UCHL1) previously unreported in NSCLC.
|
19816938 |
2010 |
Liver carcinoma
|
0.330 |
AlteredExpression
|
disease |
BEFREE |
UCHL1 is expressed in all normal tissues and immortalized normal epithelial cell lines, but was low or silenced in 77% (10/13) of HCC cell lines, which is well correlated with its promoter methylation status.
|
18666234 |
2008 |
Liver carcinoma
|
0.330 |
AlteredExpression
|
disease |
LHGDN |
UCHL1 is expressed in all normal tissues and immortalized normal epithelial cell lines, but was low or silenced in 77% (10/13) of HCC cell lines, which is well correlated with its promoter methylation status.
|
18666234 |
2008 |
Liver carcinoma
|
0.330 |
Biomarker
|
disease |
CTD_human |
UCHL1 is expressed in all normal tissues and immortalized normal epithelial cell lines, but was low or silenced in 77% (10/13) of HCC cell lines, which is well correlated with its promoter methylation status.
|
18666234 |
2008 |
Non-Small Cell Lung Carcinoma
|
0.330 |
Biomarker
|
disease |
CTD_human |
Proteomic analysis of secreted proteins of non-small cell lung cancer.
|
17094902 |
2006 |
Diaphragmatic Hernia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Abnormal development of tracheal innervation in rats with experimental diaphragmatic hernia.
|
18958481 |
2008 |